Home
ACRS
ACRS News

Latest Aclaris Therapeutics Inc. (ACRS) News on July 26, 2024

Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?

Zacks

a day ago

Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?

MT Newswires

10 days ago

Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly

Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million

GlobeNewswire

10 days ago

Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million

Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year?

Zacks

17 days ago

Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year?

MT Newswires

21 days ago

Aclaris Therapeutics Insider Bought Shares Worth $405,894, According to a Recent SEC Filing

MT Newswires

25 days ago

Aclaris Therapeutics Insider Bought Shares Worth $1,742,075, According to a Recent SEC Filing

Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire

2 months ago

Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Earnings Update: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Reported And Analysts Are Boosting Their Estimates

Simply Wall St.

3 months ago

Earnings Update: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Reported And Analysts Are Boosting Their Estimates

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Aclaris Therapeutics Inc Earnings Call

GuruFocus.com

3 months ago

Aclaris Therapeutics Inc (ACRS) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates

Zacks

3 months ago

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates

Associated Press Finance

3 months ago

Aclaris: Q1 Earnings Snapshot

Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

GlobeNewswire

3 months ago

Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update

GlobeNewswire

3 months ago

Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update

Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer

PR Newswire

3 months ago

Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer

Favourable Signals For Aclaris Therapeutics: Numerous Insiders Acquired Stock

Simply Wall St.

3 months ago

Favourable Signals For Aclaris Therapeutics: Numerous Insiders Acquired Stock

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

Is Aclaris Therapeutics (ACRS) Stock Outpacing Its Medical Peers This Year?

Zacks

4 months ago

Is Aclaris Therapeutics (ACRS) Stock Outpacing Its Medical Peers This Year?

Aclaris (ACRS) Upgraded to Buy: Here's Why

Zacks

5 months ago

Aclaris (ACRS) Upgraded to Buy: Here's Why

Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?

Zacks

5 months ago

Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?

Aclaris Therapeutics Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Aclaris Therapeutics Full Year 2023 Earnings: Beats Expectations

Analysts Have Just Cut Their Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Revenue Estimates By 51%

Simply Wall St.

5 months ago

Analysts Have Just Cut Their Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Revenue Estimates By 51%

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Tops Revenue Estimates

Zacks

5 months ago

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Tops Revenue Estimates

Associated Press Finance

5 months ago

Aclaris: Q4 Earnings Snapshot

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

GlobeNewswire

5 months ago

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

Can Aclaris Therapeutics (NASDAQ:ACRS) Afford To Invest In Growth?

Simply Wall St.

5 months ago

Can Aclaris Therapeutics (NASDAQ:ACRS) Afford To Invest In Growth?

Pacira (PCRX) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Zacks

5 months ago

Pacira (PCRX) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Will Aclaris Therapeutics (ACRS) Report Negative Q4 Earnings? What You Should Know

Zacks

5 months ago

Will Aclaris Therapeutics (ACRS) Report Negative Q4 Earnings? What You Should Know

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

Zacks

5 months ago

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

Associated Press Finance

6 months ago

Investar: Q4 Earnings Snapshot

Investar Holding Corporation Announces 2023 Fourth Quarter Results

ACCESSWIRE

6 months ago

Investar Holding Corporation Announces 2023 Fourth Quarter Results

PodcastOne Renews Agreement with The Adam Carolla Podcast and The Adam and Dr. Drew Show

GlobeNewswire

6 months ago

PodcastOne Renews Agreement with The Adam Carolla Podcast and The Adam and Dr. Drew Show

InTest Corporation (INTT) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

6 months ago

InTest Corporation (INTT) Surpasses Market Returns: Some Facts Worth Knowing

Byrna Technologies Partners with Leading Multi-Media Personality Glenn Beck

PR Newswire

6 months ago

Byrna Technologies Partners with Leading Multi-Media Personality Glenn Beck

Zacks Small Cap Research

6 months ago

AIXI: Initiating Coverage – The AI hype cycle subsides but opportunities and challenges lie ahead in 2024

Hot Stocks Roundup: Why Are People Talking About WW International and Zoom Video Communications Stocks Right Now?

Motley Fool

6 months ago

Hot Stocks Roundup: Why Are People Talking About WW International and Zoom Video Communications Stocks Right Now?

LivePerson, Inc.'s (NASDAQ:LPSN) latest 15% decline adds to one-year losses, institutional investors may consider drastic measures

Simply Wall St.

6 months ago

LivePerson, Inc.'s (NASDAQ:LPSN) latest 15% decline adds to one-year losses, institutional investors may consider drastic measures

AstroNova Updates Upcoming Investor Conference Schedule

Business Wire

6 months ago

AstroNova Updates Upcoming Investor Conference Schedule

Aclaris (ACRS) Stock Rises on Appointment of New Interim CEO

Zacks

6 months ago

Aclaris (ACRS) Stock Rises on Appointment of New Interim CEO

Why the Market Dipped But inTest Corporation (INTT) Gained Today

Zacks

6 months ago

Why the Market Dipped But inTest Corporation (INTT) Gained Today

Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024

PR Newswire

6 months ago

Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024

Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review

GlobeNewswire

6 months ago

Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review

LuxUrban Hotels Announces that The Royalton by LuxUrban, Trademark Collection® by Wyndham Will Begin Welcoming Guests in January

Business Wire

6 months ago

LuxUrban Hotels Announces that The Royalton by LuxUrban, Trademark Collection® by Wyndham Will Begin Welcoming Guests in January

Kings River Packing Becomes First in Citrus to Implement Traceability

Business Wire

6 months ago

Kings River Packing Becomes First in Citrus to Implement Traceability

A Look Back at General Merchandise Retail Stocks' Q3 Earnings: Big Lots (NYSE:BIG) Vs The Rest Of The Pack

StockStory

7 months ago

A Look Back at General Merchandise Retail Stocks' Q3 Earnings: Big Lots (NYSE:BIG) Vs The Rest Of The Pack

LuxUrban Hotels to Present at Upcoming Investor Conferences

Business Wire

7 months ago

LuxUrban Hotels to Present at Upcoming Investor Conferences

Everspin Technologies Announces Participation in 26th Annual Needham Growth Conference

Business Wire

7 months ago

Everspin Technologies Announces Participation in 26th Annual Needham Growth Conference

CI&T Releases 2024 Connected Retail Report

Business Wire

7 months ago

CI&T Releases 2024 Connected Retail Report

Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis

GlobeNewswire

7 months ago

Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis

Xiao-I and eRoad Forge Strategic Partnership to Drive Commercialization Through Xiao-I's Hua Zang Ecosystem

ACCESSWIRE

7 months ago

Xiao-I and eRoad Forge Strategic Partnership to Drive Commercialization Through Xiao-I's Hua Zang Ecosystem

Investors in Virco Mfg (NASDAQ:VIRC) have seen enviable returns of 413% over the past three years

Simply Wall St.

7 months ago

Investors in Virco Mfg (NASDAQ:VIRC) have seen enviable returns of 413% over the past three years

Focus Universal to Showcase Innovative IoT Solutions at CES 2024

ACCESSWIRE

7 months ago

Focus Universal to Showcase Innovative IoT Solutions at CES 2024

Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk

Zacks

7 months ago

Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

Zacks

7 months ago

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

CTO Realty Growth Announces Sale of Single Tenant Office Property in Tampa, FL For $22.0 Million

GlobeNewswire

7 months ago

CTO Realty Growth Announces Sale of Single Tenant Office Property in Tampa, FL For $22.0 Million

Zapata AI Research in Quantum-Enhanced Generative AI Published in Nature Communications

Business Wire

7 months ago

Zapata AI Research in Quantum-Enhanced Generative AI Published in Nature Communications

Compugen (NASDAQ:CGEN) delivers shareholders impressive 144% return over 1 year, surging 158% in the last week alone

Simply Wall St.

7 months ago

Compugen (NASDAQ:CGEN) delivers shareholders impressive 144% return over 1 year, surging 158% in the last week alone

Aclaris Therapeutics Provides Corporate Update

GlobeNewswire

7 months ago

Aclaris Therapeutics Provides Corporate Update

2 REIT Stocks You Can Buy Right Now Before They Surge Even Higher

Motley Fool

7 months ago

2 REIT Stocks You Can Buy Right Now Before They Surge Even Higher

Byrna Technologies Announces Preliminary Fiscal Fourth Quarter 2023 Revenues of $15.6 million

PR Newswire

7 months ago

Byrna Technologies Announces Preliminary Fiscal Fourth Quarter 2023 Revenues of $15.6 million

VIZSLA SILVER PUBLISHES INAUGURAL SUSTAINABILITY REPORT

CNW Group

7 months ago

VIZSLA SILVER PUBLISHES INAUGURAL SUSTAINABILITY REPORT

7 Stock Winners That Are Up 1,000% or More in 2023

InvestorPlace

7 months ago

7 Stock Winners That Are Up 1,000% or More in 2023

NW Natural Once Again Among Regional and National Leaders in Customer Satisfaction

Business Wire

8 months ago

NW Natural Once Again Among Regional and National Leaders in Customer Satisfaction

Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia

GlobeNewswire

8 months ago

Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia

Mama’s Creations to Host Third Quarter Fiscal 2024 Earnings Call on December 12 at 4:30 p.m. Eastern Time

GlobeNewswire

8 months ago

Mama’s Creations to Host Third Quarter Fiscal 2024 Earnings Call on December 12 at 4:30 p.m. Eastern Time

Aclaris (ACRS) Loses -83.17% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

8 months ago

Aclaris (ACRS) Loses -83.17% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

While individual investors own 31% of LightInTheBox Holding Co., Ltd. (NYSE:LITB), public companies are its largest shareholders with 33% ownership

Simply Wall St.

8 months ago

While individual investors own 31% of LightInTheBox Holding Co., Ltd. (NYSE:LITB), public companies are its largest shareholders with 33% ownership

PR Newswire

8 months ago

LightInTheBox Reports Third Quarter 2023 Financial Results

Baozun Inc. (NASDAQ:BZUN) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Baozun Inc. (NASDAQ:BZUN) Q3 2023 Earnings Call Transcript

Insider Sell Alert: EVP Jonathan Gottsegen Trades Shares of BrightView Holdings Inc

GuruFocus.com

8 months ago

Insider Sell Alert: EVP Jonathan Gottsegen Trades Shares of BrightView Holdings Inc

Baozun (BZUN) Q3 2023 Earnings Call Transcript

Motley Fool

8 months ago

Baozun (BZUN) Q3 2023 Earnings Call Transcript

PR Newswire

8 months ago

Baozun Announces Third Quarter 2023 Unaudited Financial Results

PR Newswire

8 months ago

LightInTheBox to Report Third Quarter 2023 Financial Results on Tuesday, November 28, 2023

TH International Limited (NASDAQ:THCH) Screens Well But There Might Be A Catch

Simply Wall St.

8 months ago

TH International Limited (NASDAQ:THCH) Screens Well But There Might Be A Catch

Down -84.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Aclaris (ACRS)

Zacks

8 months ago

Down -84.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Aclaris (ACRS)

Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update

PR Newswire

8 months ago

Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update

Looking for the Next Nvidia? Try These 3 Small-Cap Chip Stocks

InvestorPlace

8 months ago

Looking for the Next Nvidia? Try These 3 Small-Cap Chip Stocks

Jiayin Group Inc. to Release Third Quarter 2023 Unaudited Financial Results on Wednesday, November 22, 2023

GlobeNewswire

8 months ago

Jiayin Group Inc. to Release Third Quarter 2023 Unaudited Financial Results on Wednesday, November 22, 2023

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

GlobeNewswire

9 months ago

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q3 2023 SoundThinking Inc Earnings Call

PR Newswire

9 months ago

Baozun to Announce Third Quarter Financial Results of 2023 Unaudited Financial Results on November 22, 2023

Precigen to Participate in the Stifel 2023 Healthcare Conference

PR Newswire

9 months ago

Precigen to Participate in the Stifel 2023 Healthcare Conference

ThredUp (TDUP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

9 months ago

ThredUp (TDUP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Root Inc (ROOT) Q3 2023 Earnings: New Writings Double, Loss Ratio Improves

GuruFocus.com

9 months ago

Root Inc (ROOT) Q3 2023 Earnings: New Writings Double, Loss Ratio Improves

Share on Social Networks: